📋 Tender Overview
Project Number: 49742
Company Name: India Life Sciences Fund IV
Date SPI Disclosed: Jun 26, 2024
Country: India
Region: South Asia
Projected Board Date: Jul 29, 2024
Environmental Category: FI-2
Status: Pending Approval
Department: Disruptive Tech, Service & Funds
Industry: Funds
Sector: Growth Equity Fund
Project Description
IFC proposes an equity investment of up to US$25 million in India Life Sciences Fund IV (the Fund or Fund IV ), a private equity fund (PE) fund focused on providing growth capital to small and mid-market healthcare companies across (i) pharmaceuticals; (ii) healthcare delivery; (iii) medtech; (iv) specialty ingredients; (v) animal health; and (vi) other allied areas, and together with India Life Sciences Fund IV Domestic (Domestic Fund) is targeting US$325 million in total commitments. The Fund is expected to size its average ticket per company in the range of US$10-50 million in 12-15 companies.
Total Project Cost and amount and nature of IFC's Investment: The Fund, together with the Domestic Fund, is seeking to raise US$325 million in aggregate capital commitments. IFC proposes an equity investment of up to US$25 million in the Fund (capped at 19.99% of the total commitments).
Financing Sources:
2) World Bank (WB)
1818 H Street, NW Washington, DC 20433 USA
Tel : (202) 473-1000
https://www.worldbank.org/
